Resumen de acción COO
The Cooper Companies, Inc., junto con sus filiales, desarrolla, fabrica y comercializa lentes de contacto. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 3/6 |
| Rendimiento pasado | 4/6 |
| Salud financiera | 5/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
COO ha superado nuestros controles de riesgos.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
US$114.29
FV
12.8% undervalued intrinsic discount8.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative
Competidores de The Cooper Companies, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$99.63 |
| Máximo en las últimas 52 semanas | US$112.38 |
| Mínimo de 52 semanas | US$82.22 |
| Beta | 0.99 |
| 1Cambio en 1 mes | -8.23% |
| Variación en 3 meses | 5.83% |
| Cambio de 1 año | 18.21% |
| 3Variación en 3 años | -1.62% |
| Variación en 5 años | 29.47% |
| Variación desde la OPV | 1,191.69% |
Noticias y actualizaciones recientes
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01
Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15Recent updates
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03Rentabilidad de los accionistas
| COO | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -4.0% | -1.1% | -2.2% |
| 1Y | 18.2% | 23.0% | 30.1% |
Rentabilidad vs. Industria: Los resultados de COO fueron inferiores a los de la industria US Medical Equipment, que obtuvo un rendimiento del 23% el año pasado.
Rentabilidad vs. Mercado: COO obtuvo unos resultados inferiores a los del mercado US, que fueron del 30.1% el año pasado.
Volatilidad de los precios
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: COO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de COO (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., junto con sus filiales, desarrolla, fabrica y comercializa lentes de contacto. La empresa opera en dos segmentos, CooperVision y CooperSurgical. El segmento CooperVision ofrece lentes esféricas, que incluyen lentes que corrigen la miopía y la hipermetropía; y lentes tóricas y multifocales, que incluyen lentes que corrigen problemas de visión, como el astigmatismo, la presbicia y la miopía en América, Europa, Oriente Medio, África y Asia-Pacífico.
Resumen de fundamentos de The Cooper Companies, Inc.
| Estadísticas fundamentales de COO | |
|---|---|
| Capitalización bursátil | US$19.89b |
| Beneficios(TTM) | US$359.30m |
| Ingresos (TTM) | US$3.80b |
55.2x
Ratio precio-beneficio (PE)5.2x
Ratio precio-ventas (PS)¿Está COO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de COO | |
|---|---|
| Ingresos | US$3.80b |
| Coste de los ingresos | US$1.28b |
| Beneficio bruto | US$2.52b |
| Otros gastos | US$2.17b |
| Beneficios | US$359.30m |
Últimos beneficios comunicados
Jul 31, 2024
Próxima fecha de beneficios
Dec 05, 2024
| Beneficios por acción (BPA) | 1.80 |
| Margen bruto | 66.36% |
| Margen de beneficio neto | 9.45% |
| Ratio deuda/patrimonio | 33.2% |
¿Cómo se ha desempeñado COO a largo plazo?
Ver rendimiento histórico y comparativa